HIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702-1201, USA.
Gene Ther. 2013 Feb;20(2):169-76. doi: 10.1038/gt.2012.18. Epub 2012 Mar 8.
Although novel retroviral vectors for use in gene-therapy products are reducing the potential for formation of replication-competent retrovirus (RCR), it remains crucial to screen products for RCR for both research and clinical purposes. For clinical-grade gammaretrovirus-based vectors, RCR screening is achieved by an extended S(+)L(-) or marker-rescue assay, whereas standard methods for replication-competent lentivirus detection are still in development. In this report, we describe a rapid and sensitive method for replication-competent gammaretrovirus detection. We used this assay to detect three members of the gammaretrovirus family and compared the sensitivity of our assay with well-established methods for retrovirus detection, including the extended S(+)L(-) assay. Results presented here demonstrate that this assay should be useful for gene-therapy product testing.
虽然用于基因治疗产品的新型逆转录病毒载体减少了形成复制型逆转录病毒 (RCR) 的可能性,但出于研究和临床目的,仍然需要对产品进行 RCR 筛查。对于临床级γ逆转录病毒载体,通过扩展 S(+)L(-) 或标记拯救测定法来实现 RCR 筛查,而用于检测复制型慢病毒的标准方法仍在开发中。在本报告中,我们描述了一种用于检测复制型γ逆转录病毒的快速灵敏方法。我们使用该测定法检测了三种γ逆转录病毒家族成员,并将我们的测定法与用于逆转录病毒检测的成熟方法(包括扩展 S(+)L(-) 测定法)的灵敏度进行了比较。这里呈现的结果表明,该测定法对于基因治疗产品测试应该是有用的。